Disfonía como efecto secundario dosis dependiente del tratamiento con duloxetina

Tamara Rivero Salvador; Clara Marín Zaldivar; Pablo Baltanas Rubio; Laura  Ciercoles Ramirez; Esther Cuesta Peribañez; Lucia Gimeno Garcés; María del Pueyo Badel Rubio

doi:10.20986/resed.2017.3528/2016

Vol. 25 No. 6 (2018), Caso Clínico

Vol. 25 No. 6 (2018)

Dysphonia as side-effect dose-dependent during treatment with duloxetine

Caso Clínico

Published 2018-12-13

Tamara Rivero Salvador⁺⁻
Clara Marín Zaldivar⁺⁻
Pablo Baltanas Rubio⁺⁻
Laura Ciercoles Ramirez⁺⁻
Esther Cuesta Peribañez⁺⁻
Lucia Gimeno Garcés⁺⁻
María del Pueyo Badel Rubio⁺⁻

Tamara Rivero Salvador

H. C. U. Lozano Blesa

Clara Marín Zaldivar

H. C. U. Lozano Blesa

Pablo Baltanas Rubio

Clinico Lozano Blesa

Laura Ciercoles Ramirez

Complejo Hospitalario de Navarra

Esther Cuesta Peribañez

H. C. U. Lozano Blesa

Lucia Gimeno Garcés

H. C. U. Lozano Blesa

María del Pueyo Badel Rubio

H. C. U. Lozano Blesa

PDF (Spanish)

Keywords

Duloxetine
side effects
dysphonia.

Abstract

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) is indicated for the management of major depressive disorder and neuropathic pain. The dose recommended for neuropathic pain is 60 mg once a day.

PDF (Spanish)

Downloads

Download data is not yet available.